These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7913369)

  • 21. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
    Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
    Cho Mar K; Eimoto T; Nagaya S; Tateyama H
    Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of metallothionein (MT) and Ki-67 antigen expression in benign and malignant thyroid tumours.
    Królicka A; Kobierzycki C; Puła B; Podhorska-Okołów M; Piotrowska A; Rzeszutko M; Rzeszutko W; Rabczyński J; Domosławski P; Wojtczak B; Dawiskiba J; Dzięgiel P
    Anticancer Res; 2010 Dec; 30(12):4945-9. PubMed ID: 21187474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
    Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F
    Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The investigation of galectin-3 in diseases of the thyroid gland.
    Kovács RB; Földes J; Winkler G; Bodó M; Sápi Z
    Eur J Endocrinol; 2003 Nov; 149(5):449-53. PubMed ID: 14585093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
    Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
    Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
    Barresi V; Leni A; Tuccari G; Barresi G
    Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.
    Ferru A; Denis S; Guilhot J; Gibelin H; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
    Eur J Surg Oncol; 2006 Mar; 32(2):228-30. PubMed ID: 16290057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
    Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
    Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
    Soares P; Sobrinho-Simöes M
    Cancer; 1994 Jun; 73(11):2879-81. PubMed ID: 7910779
    [No Abstract]   [Full Text] [Related]  

  • 34. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
    Mehrotra A; Goel MM; Singh K
    Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
    Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
    Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.